Oncogenic activation of the KRAS gene occurs in >90% of pancreatic ductal carcinoma and malignant progression from pancreatic intraepithelial carcinoma to a more aggressive form of pancreatic cancer is accompanied by the early acquisition of KRAS oncogene activation (21,22). The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.